Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.
about
Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract InfectionsCystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to TreatThe role of the bacterial microbiome in lung diseaseThe metabolic footprint of the airway bacterial community in cystic fibrosis.Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.Interpreting infective microbiota: the importance of an ecological perspective.Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbationsAnalysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear periodComplexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia.The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbationLung microbiota across age and disease stage in cystic fibrosis.The bacterial microbiota in inflammatory lung diseasesRespiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial interventionAnalysis of the association between host genetics, smoking, and sputum microbiota in healthy humans.Examining changes in bacterial abundance in complex communities using next-generation sequencing is enhanced with quantitative PCR.Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation.Cystic fibrosis and physiological responses to exercise.Bacterial Adaptation during Chronic Respiratory Infections.How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?Understanding persistent bacterial lung infections: clinical implications informed by the biology of the microbiota and biofilmsThe Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis.The cystic fibrosis lung microbiome.Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.
P2860
Q26752371-98A02007-EE85-4BC2-97E9-28B1C7C20ABCQ26771468-F45261AE-DE60-4BFF-A9B1-571C7BDFF12CQ33554623-B500A9E0-8F4C-4327-A99C-E5530B0F0152Q33861701-297AD57D-C22E-4AAD-B247-95AF4F44DD43Q34353683-9E6EFB7B-189A-4156-AD28-439635EED3ECQ34677317-42CB8DF6-17D6-4A8A-B04D-EAA94FE6D1E5Q34706914-FF3EADA8-41D9-468B-8E5B-5D72702F6F9DQ34916610-9E9A95F6-FC4D-4B7B-803D-87DECE61C1E3Q34997989-E8E80E07-B209-4BF1-8C55-8EEE72C509D6Q35237897-051F6883-D34E-46E3-BA2F-5D815B7CF543Q35605802-62B2FEB8-9E37-4D62-B2AE-4E186BF5ED9DQ35677622-64334993-DDEA-46A3-83FA-FB30F0437AC3Q35837327-DA4D42E2-07A8-4A9B-9788-6F4041427911Q35974682-48976EB3-7D29-4E64-BC80-278A26070BB4Q36012672-92E56A0B-106F-43B4-A05E-75D96C1D0F34Q36257805-6F5513E2-D1C1-44E7-ADDC-A445F2548BAFQ37677382-46AF6401-9598-427E-8230-153A5A443F85Q38268014-B874AC05-8925-471C-8A41-8ECBCB30F07FQ38367560-CAD8E995-9870-43AD-B2AC-8171FD984308Q38635041-C4BC8F70-CF6E-4534-B9C2-D23739C6D7D3Q39167799-07582EB2-2796-4F84-BDAC-B1FC6649D74BQ39328796-E861DDB9-9F65-4171-9392-F6B1390CB539Q46263483-9F5F16C7-C7ED-49B4-809E-A8289D043349Q46944983-66465777-44BD-4A23-856F-DFF8444960A6Q47814293-72F54666-D6DF-4D2D-8AD0-65CBBE656B20
P2860
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Impact of antibiotic treatment ...... diversity in cystic fibrosis.
@ast
Impact of antibiotic treatment ...... diversity in cystic fibrosis.
@en
Impact of antibiotic treatment ...... diversity in cystic fibrosis.
@nl
type
label
Impact of antibiotic treatment ...... diversity in cystic fibrosis.
@ast
Impact of antibiotic treatment ...... diversity in cystic fibrosis.
@en
Impact of antibiotic treatment ...... diversity in cystic fibrosis.
@nl
prefLabel
Impact of antibiotic treatment ...... diversity in cystic fibrosis.
@ast
Impact of antibiotic treatment ...... diversity in cystic fibrosis.
@en
Impact of antibiotic treatment ...... diversity in cystic fibrosis.
@nl
P2093
P1476
Impact of antibiotic treatment ...... l diversity in cystic fibrosis
@en
P2093
C J van der Gast
F A Stressmann
G B Rogers
M P Carroll
P356
10.1016/J.JCF.2012.05.008
P577
2012-06-18T00:00:00Z